Bristol-Myers raised the worth on 10 medication on Wednesday, including 1.5 p.c hikes on cancer immunotherapies Opdivo and Yervoy and a 6 percent increase on its blood thinner Eliquis, all of which bring in billions of dollars in income yearly.
As Eire moves towards a formalized generic medicine policy, a possibility presents itself to ensure the reimbursement costs are close to market worth (including savings related to quantity reductions referred to earlier) and that the benefits of the brand new policy do not accrue disproportionately to the pharmacists and their wholesalers and drugs distributors.
Dr. Massey is Chief Life Sciences Officer at Saama Technologies, responsible for driving market management for Saama's award-profitable life sciences knowledge analytics options. FL and MZL are sorts of most cancers of white blood cells known as B-cell lymphocytes which are discovered in the lymph nodes and spleen.
Dimopoulos M, Spencer A, Attal M, et al. Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma. lenalidomide interactions
(lenalidomide) oral capsules are indicated for the treatment of Mantle Cell Lymphoma (MCL). Revlimid is a specialty chemotherapy drug prescribed to help treat myelodysplastic syndrome, mantle cell lymphoma, and a number of myeloma.